Ion Beam Applications (XBRU:IBAS) Debt-to-Equity : 0.39 (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Ion Beam Applications Debt-to-Equity?

Ion Beam Applications's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €12.57 Mil. Ion Beam Applications's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €29.01 Mil. Ion Beam Applications's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €106.21 Mil. Ion Beam Applications's debt to equity for the quarter that ended in Dec. 2023 was 0.39.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Ion Beam Applications's Debt-to-Equity or its related term are showing as below:

XBRU:IBAS' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.19 Med: 0.39 Max: 0.97
Current: 0.39

During the past 13 years, the highest Debt-to-Equity Ratio of Ion Beam Applications was 0.97. The lowest was 0.19. And the median was 0.39.

XBRU:IBAS's Debt-to-Equity is ranked worse than
65.59% of 712 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs XBRU:IBAS: 0.39

Ion Beam Applications Debt-to-Equity Historical Data

The historical data trend for Ion Beam Applications's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ion Beam Applications Debt-to-Equity Chart

Ion Beam Applications Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.61

0.55

0.35

0.39

Ion Beam Applications Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.55	0.67	0.35	0.48	0.39

Competitive Comparison of Ion Beam Applications's Debt-to-Equity

For the Medical Devices subindustry, Ion Beam Applications's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ion Beam Applications's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ion Beam Applications's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Ion Beam Applications's Debt-to-Equity falls into.

Ion Beam Applications Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Ion Beam Applications's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(12.573	+	29.01)	/	106.212
	=	0.39

Ion Beam Applications's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(12.573	+	29.01)	/	106.212
	=	0.39

Ion Beam Applications (XBRU:IBAS) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Ion Beam Applications Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Ion Beam Applications's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Ion Beam Applications (XBRU:IBAS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ion Beam Applications SA (XBRU:IBAS) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

IOBCF:USA 0GZK:UK IOB:Germany IBAB:Belgium

Address

Chemin du Cyclotron, 3, Louvain-La-Neuve, BEL, B-1348

Website

https://www.iba-worldwide.com

Ion Beam Applications SA develops and manufactures medical devices and software solutions. The firm operates in two segments: proton therapy and other accelerators and dosimetry. Proton therapy and other accelerators business contribute to the majority of sales. It offers solutions for precision cancer treatment through the use of proton beams, as well as cyclotrons used for the production of radioisotopes and industrial accelerators for sterilization and ionization. The dosimetry business sells measurement and quality assurance instruments for radiotherapy and medical imaging. The firm operates in three geographical areas: Belgium, the United States, and the Rest of the World, with REst-of-World sales generating the largest proportion of revenue.

Ion Beam Applications (XBRU:IBAS) Headlines

No Headlines